Bionano Genomics (BNGO) Competitors $3.04 -0.17 (-5.30%) Closing price 04:00 PM EasternExtended Trading$3.00 -0.04 (-1.35%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNGO vs. DAIO, CLIR, STAI, MSAI, PRPO, ASTC, TLIS, SMIT, TBIO, and SPECShould you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Data I/O (DAIO), ClearSign Technologies (CLIR), ScanTech AI Systems (STAI), MultiSensor AI (MSAI), Precipio (PRPO), Astrotech (ASTC), Talis Biomedical (TLIS), Schmitt Industries (SMIT), Telesis Bio (TBIO), and Spectaire (SPEC). These companies are all part of the "measuring and control equipment" industry. Bionano Genomics vs. Its Competitors Data I/O ClearSign Technologies ScanTech AI Systems MultiSensor AI Precipio Astrotech Talis Biomedical Schmitt Industries Telesis Bio Spectaire Bionano Genomics (NASDAQ:BNGO) and Data I/O (NASDAQ:DAIO) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation. Do analysts recommend BNGO or DAIO? Bionano Genomics currently has a consensus price target of $7.00, indicating a potential upside of 130.26%. Data I/O has a consensus price target of $5.22, indicating a potential upside of 57.70%. Given Bionano Genomics' higher probable upside, research analysts clearly believe Bionano Genomics is more favorable than Data I/O.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25Data I/O 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders believe in BNGO or DAIO? 11.4% of Bionano Genomics shares are owned by institutional investors. Comparatively, 37.0% of Data I/O shares are owned by institutional investors. 0.9% of Bionano Genomics shares are owned by insiders. Comparatively, 2.6% of Data I/O shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility and risk, BNGO or DAIO? Bionano Genomics has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Comparatively, Data I/O has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Which has stronger earnings & valuation, BNGO or DAIO? Data I/O has lower revenue, but higher earnings than Bionano Genomics. Data I/O is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionano Genomics$30.78M0.33-$112.02M-$138.92-0.02Data I/O$21.77M1.43-$3.09M-$0.28-11.82 Does the media prefer BNGO or DAIO? In the previous week, Bionano Genomics had 7 more articles in the media than Data I/O. MarketBeat recorded 9 mentions for Bionano Genomics and 2 mentions for Data I/O. Bionano Genomics' average media sentiment score of 0.77 beat Data I/O's score of 0.29 indicating that Bionano Genomics is being referred to more favorably in the media. Company Overall Sentiment Bionano Genomics Positive Data I/O Neutral Is BNGO or DAIO more profitable? Data I/O has a net margin of -11.49% compared to Bionano Genomics' net margin of -271.02%. Data I/O's return on equity of -14.60% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Bionano Genomics-271.02% -130.31% -71.18% Data I/O -11.49%-14.60%-10.62% SummaryData I/O beats Bionano Genomics on 9 of the 14 factors compared between the two stocks. Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNGO vs. The Competition Export to ExcelMetricBionano GenomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.80M$3.11B$5.63B$9.83BDividend YieldN/A2.23%3.79%4.08%P/E RatioN/A7.0921.9023.75Price / Sales0.33367.51465.67116.64Price / CashN/A42.3037.4059.05Price / Book0.178.659.096.18Net Income-$112.02M-$54.65M$3.25B$264.89M7 Day Performance4.47%6.59%4.76%2.66%1 Month Performance-10.06%9.57%6.72%3.05%1 Year Performance-90.20%14.06%30.51%25.05% Bionano Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNGOBionano Genomics2.4621 of 5 stars$3.04-5.3%$7.00+130.3%-87.3%$10.80M$30.78M0.00300News CoverageEarnings ReportDAIOData I/O1.7513 of 5 stars$3.20+1.2%$5.22+63.2%+40.7%$29.56M$21.77M-11.42100Short Interest ↑CLIRClearSign Technologies2.9366 of 5 stars$0.55+0.4%$2.00+265.6%-17.4%$28.68M$2.90M-4.5610News CoverageEarnings ReportGap DownSTAIScanTech AI SystemsN/A$0.59+1.8%N/AN/A$28.39M$907.64K0.00N/AGap UpMSAIMultiSensor AI3.357 of 5 stars$0.80+2.7%$2.50+212.5%-50.9%$26.75M$7.40M0.0035Earnings ReportPRPOPrecipio1.5153 of 5 stars$14.51+0.3%N/A+192.4%$21.91M$18.53M-7.0160News CoverageEarnings ReportShort Interest ↓ASTCAstrotech0.9294 of 5 stars$5.36+2.0%N/A-42.6%$8.90M$903K-0.6410News CoverageShort Interest ↑Gap UpTLISTalis BiomedicalN/A$1.50flatN/A-62.6%$2.73M$300K-0.05260Upcoming EarningsSMITSchmitt IndustriesN/A$0.02flatN/AN/A$69K$9.89M0.00160TBIOTelesis BioN/A$0.02flatN/A-99.4%$40K$225.09M0.00200SPECSpectaireN/A$0.00flatN/A-99.6%$6KN/A0.008 Related Companies and Tools Related Companies DAIO Alternatives CLIR Alternatives STAI Alternatives MSAI Alternatives PRPO Alternatives ASTC Alternatives TLIS Alternatives SMIT Alternatives TBIO Alternatives SPEC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNGO) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access